Julio Granados Selected Research

HLA-DQbeta antigen

2/2007	MHC class II genes in Mexican patients with idiopathic dilated cardiomyopathy.
5/2004	[Association of the HLA-DQB*0501, allele of the major histocompatibility complex with gastric cancer in Mexico].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julio Granados Research Topics

Disease

16	Genetic Predisposition to Disease (Genetic Predisposition) 08/2021 - 01/2003
10	Infections 01/2022 - 11/2002
8	Obesity 12/2021 - 07/2010
6	Tuberculosis (Tuberculoses) 06/2020 - 12/2005
5	Neoplasms (Cancer) 01/2021 - 05/2011
5	Rheumatoid Arthritis 01/2020 - 02/2004
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2012
3	COVID-19 01/2022 - 01/2021
3	Rheumatic Diseases (Rheumatism) 06/2020 - 05/2011
3	Ulcerative Colitis 01/2020 - 08/2004
3	Leprosy (Hansen's Disease) 01/2017 - 11/2013
3	Papillomavirus Infections 08/2013 - 10/2004
2	Critical Illness (Critically Ill) 01/2022 - 10/2015
2	Human Influenza (Influenza) 01/2021 - 10/2015
2	Neuromyelitis Optica (Devic's Disease) 01/2021 - 01/2018
2	Vitiligo 01/2021 - 01/2005
2	Overweight 08/2020 - 11/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2018 - 02/2007
2	Onychomycosis (Tinea Unguium) 09/2016 - 12/2010
2	Systemic Scleroderma (Systemic Sclerosis) 07/2016 - 01/2015
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2014 - 04/2008
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2013 - 07/2007
2	Hypertension (High Blood Pressure) 01/2013 - 02/2005
2	Dengue (Dengue Fever) 10/2011 - 11/2002
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2011 - 01/2009
2	Type 2 Diabetes Mellitus (MODY) 07/2010 - 02/2007
2	Autoimmune Hepatitis 01/2009 - 03/2007
2	Pemphigus (Pemphigus Vulgaris) 09/2007 - 04/2005
2	Gastritis 12/2006 - 05/2004
2	Reactive Arthritis (Reiter Disease) 10/2006 - 12/2004
2	Ankylosing Spondylitis 10/2006 - 12/2004
1	Melanoma (Melanoma, Malignant) 09/2022
1	Dyslipidemias (Dyslipidemia) 12/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2021
1	Gastroesophageal Reflux (GERD) 05/2021
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2021
1	Acute Coronary Syndrome 12/2020
1	Atherosclerotic Plaque (Atheroma) 12/2020
1	Allergic Rhinitis 01/2020
1	Abdominal Aortic Aneurysm 01/2019
1	Pediatric Obesity 01/2019
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 01/2019
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2019
1	Insulinoma 12/2018
1	Non-alcoholic Fatty Liver Disease 08/2018

Drug/Important Bio-Agent (IBA)

15	HLA-DRB1 Chains (HLA DRB1)IBA 09/2022 - 01/2003
11	HLA Antigens (Human Leukocyte Antigens)IBA 09/2022 - 07/2002
10	HLA-DR Antigens (HLA-DR)IBA 09/2016 - 03/2002
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2020 - 08/2003
9	AntigensIBA 12/2018 - 03/2002
7	CytokinesIBA 05/2021 - 02/2005
5	HLA-DQB1 antigen (HLA DQB1)IBA 09/2022 - 05/2004
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2004
4	CholesterolIBA 12/2021 - 07/2010
4	Genetic Markers (Genetic Marker)IBA 11/2019 - 01/2009
4	AutoantibodiesIBA 12/2018 - 01/2009
3	EnzymesIBA 08/2020 - 12/2006
3	HLA-A Antigens (HLA-A)IBA 01/2018 - 11/2009
3	AntibodiesIBA 02/2016 - 03/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 11/2002
3	HLA-B Antigens (HLA-B)IBA 01/2013 - 01/2005
3	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 10/2004 - 07/2002
2	HLA-DQA1 antigen (HLA DQA1)IBA 09/2022 - 05/2004
2	Apolipoproteins B (ApoB)IBA 12/2021 - 05/2017
2	LipidsIBA 12/2021 - 10/2009
2	Histocompatibility Antigens Class IIIBA 01/2021 - 08/2013
2	HLA-DRB1*04 antigenIBA 01/2021 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 10/2015
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2020
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021 - 10/2015
2	ChemokinesIBA 12/2020 - 10/2015
2	Peptides (Polypeptides)IBA 01/2020 - 01/2018
2	Type 1 Angiotensin ReceptorIBA 07/2016 - 01/2013
2	Tuberculin (PPD)IBA 02/2016 - 02/2010
2	HLA-DR7 Antigen (HLA DR7 Antigen)IBA 01/2011 - 07/2002
2	Apolipoproteins E (ApoE)IBA 10/2010 - 10/2009
2	ApolipoproteinsIBA 10/2009 - 09/2002
2	HLA-DQbeta antigenIBA 02/2007 - 05/2004
2	HLA-DQ Antigens (HLA-DQ)IBA 12/2006 - 05/2004
1	HLA-A*68 antigenIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	oxidized low density lipoproteinIBA 12/2021
1	Inflammation MediatorsIBA 05/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	3,3,5,5-tetramethyl-1-pyrroline N-oxide (TMPO)IBA 01/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	Ifosfamide FDA LinkGeneric 01/2021
1	Thymopoietins (TP 49)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	2-benzyl-3-formylpropanoic acid (BFP)IBA 08/2020
1	AntioxidantsIBA 08/2020
1	Tumor Necrosis Factor InhibitorsIBA 06/2020
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	AdipokinesIBA 01/2019
1	Insulin (Novolin)FDA Link 12/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 12/2018
1	Immunoglobulin G (IgG)IBA 01/2018

Therapy/Procedure

5	Therapeutics 06/2020 - 11/2013